1 / 34

MACULAR DEGENERATION AND HEREDITARY RETINAL DYSTROPHIES

MACULAR DEGENERATION AND HEREDITARY RETINAL DYSTROPHIES. DR. SİNAN TATLIPINAR. ANATOMY. CLINICAL EVALUATION. Sx: -Decreased central vision, metamorphopsia, micropsia, macropsia Ancillary tests: -FFA: fundus fluorescein angiography, OCT: optical coherence tomography. AGE-RELATED MACULAR

dcheney
Download Presentation

MACULAR DEGENERATION AND HEREDITARY RETINAL DYSTROPHIES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MACULAR DEGENERATION AND HEREDITARY RETINAL DYSTROPHIES DR. SİNAN TATLIPINAR

  2. ANATOMY

  3. CLINICAL EVALUATION • Sx: -Decreased central vision, metamorphopsia, micropsia, macropsia • Ancillary tests: -FFA: fundus fluorescein angiography, OCT: optical coherence tomography

  4. AGE-RELATED MACULAR DEGENERATION (AMD) 1. Atrophic AMD (Dry, nonexudative) 2. Exudative AMD • Choroidal neovascularization (CNV) -After 50 yr of age -AMD is the most common cause of visual loss in individuals over age 50. -Risk factors:Age, heredity, smoking

  5. Drusen Histopathology Hard Soft • Larger, ill-defined spots • Small well-defined • spots • May enlarge and coalesce • Usually innocuous • Increased risk of AMD

  6. `` FA of drusen Degree of hyperfluorescence depends on: • Extent of overlying RPE atrophy (window defect) • Amount of staining • Lipid content

  7. Drusen and AMD - progression Exudative AMD Atrophic AMD

  8. Atrophic AMD Progression Initially drusen and non-specific RPE changes Late RPE (geographic) atrophy

  9. Atrophic AMD Fluorescein angiogram Management Hyperfluorescence from RPE window defect Low-vision aids if appropriate

  10. Choroidal neovascularization (CNV) • Less common than atrophic AMD but more serious • Metamorphopsia is initial symptom Suspicious clinical signs Subretinal blood or lipid Pinkish-yellow subretinal lesion with fluid

  11. Angiographic classification of CNV Occult Well-defined (classical) • Extrafoveal > 200 m from centre of • FAZ • Poorly defined • Juxtafoveal < 200 m from centre of • FAZ • Obscured by PED, blood or exudate • Subfoveal - involving centre of FAZ

  12. FA of classical CNV Leakage into subretinal space and around CNV Late staining Very early ‘lacy’ filling pattern

  13. Possible subsequent course of CNV Subretinal (disciform) scarring Haemorrhagic sensory and RPE detachment Massive subretinal exudation Exudative retinal detachment

  14. TREATMENT • ATROPHIC AMD: AREDS supplements • EXUDATIVE AMD: -Laser photocoagulation -Photodynamic Therapy -Intravitreal injection of anti-VEGF agents

  15. OTHER ACQUIRED MACULOPATHIES 1. Central serous retinopathy 2. Idiopathic macular hole 3. Idiopathic premacular fibrosis 4. Cystoid macular oedema 5. Myopic maculopathy

  16. Central serous retinopathy ( CSR ) • Self-limiting disease of young or middle-aged men • Usually unilateral • Localized, shallow detachment of sensory retina at posterior pole • Often outlined by glistening reflex

  17. FA of central serous retinopathy (1) Smoke-stack appearance Early hyperfluorescent spot Later dye passage into subretinal space and vertical ascend Subsequent lateral spread until entire area filled

  18. FA of central serous retinopathy (2) Ink-blot appearance - less common Early hyperfluorescent spot Subsequent concentric spread until entire area filled

  19. Treatment of central serous retinopathy Most cases are self-limiting and do not require treatment Laser photocoagulation to RPE leak Post-treatment Pre-treatment • 4 months should elapse before considering treatment • Treatment induces resolution and lowers recurrence rate • Does not influence final visual outcome

  20. Staging of idiopathic macular hole Stage 1a ( impending ) Stage 1b (occult) Normal fovea Stage 1a - ( impending hole ) Stage 1b - ( occult hole ) Dehiscence of photoreceptors Vitreous contraction with foveal detachment Stage 4 Stage 3 Stage 2 Seperation of cortex from retinal surface to form pseudo-operculum Complete vitreous separation Seperation of pseudo- operculum from edge of hole

  21. Clinical features of full-thickness macular hole • Typically affects elderly females • Eventually bilateral in 10% • VA about 6/60 • Round punched-out area at fovea • Multiple yellow deposits within crater • Surrounding halo of sub-retinal fluid • Positive Watzke-Allen sign

  22. Idiopathic premacular fibrosis Cellophane maculopathy Macular pucker • Severe retinal wrinkling and • vascular distortion • Opaque epiretinal membrane • Translucent epiretinal • membrane • May be associated with • macular pseudo-hole • Pucker emanating from • epicentre • Fine retinal striae and mild • vascular distortion

  23. Cystoid macular oedema ( CMO ) Fluid-filled microcysts in outer plexiform and inner nuclear layer May lead to lamellar hole formation if longstanding

  24. Important causes of CMO Retinal vein occlusion Background diabetic retinopathy Intermediate uveitis Post-cataract surgery

  25. Clinical diagnosis of CMO • Loss of foveal depression • Retinal thickening • Yellow spot at foveola • Multiple cystoid areas

  26. FA of cystoid macular oedema Late pooling with ‘flower-petal’ pattern Early parafoveal leakage Coalescence of leaking points

  27. Myopic maculopathy Atrophic ‘Lacquer cracks’ • Large breaks in Bruch membrane • Progressive chorioretinal atrophy • May be associated with macular hole • Develop in about 5% of highly myopic eyes Macular haemorrhage Fuchs spot • Secondary pigment proliferation • From CNV with lacquer cracks • From lacquer cracks alone • Follows absorption of blood

  28. Other fundus changes in myopia Tilted disc Posterior staphylomas Peripheral chorioretinal degeneration Lattice degeneration, holes and retinal detachment

  29. HEREDITARY RETINAL DYSTROPHIES 1. Photoreceptor dystrophies • Retinitis pigmentosa • Retinitis punctata albescens • Fundus albipunctatus • Cone dystrophy • Leber congenital amaurosis 2. Retinal pigment epithelial dystrophies • Best vitelliform macular dystrophy • Adult best vitelliform macular dystrophy • Stargardt macular dystrophy • Fundus flavimaculatus • Familial dominant drusen • Sorsby pseudo-inflammatory macular dystrophy

  30. Retinitis Pigmentosa 1. Inheritance • Sporadic (23%) • Dominant (43%) • Recessive (20%) • X-linked recessive (8%) • Uncertain (6%) 2. Presents- usually prior to 30 years 3. Prognosis- dominant best, x-linked worst 4. ERG- reduced

  31. Progression of retinitis pigmentosa • Perivascular ‘bone-spicule’ • pigmentation • Fine dust-like pigmentation • Arteriolar attenuation • Initially mid-peripheral • Anterior and peripheral • spread • Optic disc pallor • Maculopathy • Unmasking of large • choroidal vessels

  32. Ocular associations of retinitis pigmentosa Keratoconus (uncommon) Cataract (very common) Vitreous degeneration (common) Optic disc drusen (uncommon) Myopia (common) Open-angle glaucoma (uncommon

  33. Atypical retinitis pigmentosa Quadrantic Sectorial Pericentric Paravenous

More Related